Nihon Kohden Corporation
NHNKY
Other OTC9.42
USD
-0.12
- -
CIK
0001543726
ISIN
US65412C1080
CUSIP
65412C108
Return %
Stock
S&P500
1Y
-25.24
17.85
3Y
-30.99
64.56
5Y
-39.07
69.89
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Hirokazu Ogino
- Full Time Employees
- 6,116
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 1-31-4 Nishiochiai Tokyo TY Japan 161-8560
- IPO Date
- Sep 27, 2013
- CIK
- 0001543726
- Website
- nihonkohden.com
- Similar Companies
- Business
- Nihon Kohden Corporation engages in the development, manufacturing, sale, maintenance, and consultation of medical electronic equipment and related systems. The company offers a comprehensive portfolio of products including patient monitoring systems for emergency rooms, operating rooms, intensive care units, and general wards; electroencephalograms (EEGs); electromyograms (EMG) measuring systems; electrocardiographs (ECGs); invasive and non-invasive ventilators; defibrillators; automated external defibrillators (AEDs); pacemakers; implantable cardioverter defibrillators (ICDs); clinical chemistry analyzers; and diagnostic information systems for laboratories. Nihon Kohden also provides IT systems designed to enhance hospital operational efficiency, medical care quality, and patient safety. It imports various treatment devices into Japan and operates globally with subsidiaries across the U.S., Europe, and Asia. Founded in 1951 and headquartered in Tokyo, Japan, Nihon Kohden is the largest supplier of EEG products worldwide and serves customers in over 120 countries. Recent major developments include the acquisition of a 71.4% stake in NeuroAdvanced Corp., the parent company of Ad-Tech Medical Instrument Corporation, expanding its neurology electrode device portfolio. This acquisition strengthens Nihon Kohden’s capacity to deliver comprehensive epilepsy care by combining its expertise in EEG systems with Ad-Tech’s specialized electrodes, creating greater synergy for clinicians and hospitals globally. In 2024, Nihon Kohden also formed a strategic partnership with Medasense to exclusively distribute an AI-powered nociception monitor for pain management across Japanese healthcare facilities, marking a significant advancement in patient care. Additionally, Nihon Kohden launched the Life Scope® G7 patient monitor in the U.S., an advanced bedside monitoring device with enhanced features for high-acuity clinical settings, furthering its innovation leadership in patient monitoring technology. The company has made substantial investments in research and development in its BEACON 2030 vision to enhance patient monitors, ventilators, and digital health solutions. Nihon Kohden operates primarily in the medical electronic equipment industry, targeting hospitals, clinics, emergency medical services, and healthcare providers worldwide. It maintains production and sales subsidiaries in multiple countries, including key markets in the U.S., Europe, China, Singapore, India, and Japan. The company employs over 6,000 people globally and is listed on the Tokyo Stock Exchange under ticker NHNKY (6849.T).
Nihon Kohden Upgrades NKV-550, Now First Ventilator Combining Non-Invasive Muscle Pressure Monitoring, AVM and Adjustable AdaptiveSync™ Manufactured in the U.S.
Nihon Kohden (OTCMKTS:NHNKY) versus Nuwellis (NASDAQ:NUWE) Head to Head Contrast
Nihon Kohden (OTCMKTS:NHNKY) Shares Gap Up – What’s Next?
Nihon Kohden Brings Advanced EEG Technology Built on 70 Years of Innovation to Booth #725 at the American Epilepsy Society 2025 Annual Meeting